Lupin Jumps Into High-Margin Business With $1 Billion For Acquisitions
This article was originally published in PharmAsia News
Executive Summary
Lupin has big plans for expanding around the globe and committed up to $1 billion to buy companies and brands beyond its primary markets of India, Japan and the U.S.